OncLive SOSS

The Era of Immunotherapy for Advanced Head & Neck Cancer Squamous Cell Carcinoma

EP. 11: Nivolumab-Related Efficacy and Toxicity in HNSCC Patients

December 22nd 2016

EP. 12: Patient Selection for Nivolumab in HNSCC

December 22nd 2016

EP. 13: Ongoing Research of Immunotherapy in HNSCC

December 22nd 2016

EP. 14: Emerging PD-L1 Inhibitors for HNSCC

December 22nd 2016

<
1
2
>